Skip to main content

NET not compulsory for PhD

The University Grants Commission (UGC) has amended two sets of its regulation. It has relaxed the minimum eligibility norms (NET) for the appointment of assistant professors and has granted more time for women and differently-abled scholars to complete their Ph.D and M.Phil degrees.

HRD Minister Smriti Irani announced these two new amendments in a press conference on  April 12. The idea behind these amendments is to grant lectureship to non-NET students and to promote the entry of more women and differently-abled students into the field of research.

NET not compulsory
Till now, according to the 2009 regulations, a candidates would have required at least a post-graduate or an MPhil degree along with a cleared NET or SET (State-level eligibility test) as minimum eligibility for appointment in colleges and universities as teachers and lecturers. But now, those who have completed a Ph.D or registered for a Ph.D before 2009 would be eligible for lectureship without clearing the NET, reported by The Huffington Post.

The decision has been taken keeping in mind the creation  of more job opportunities in teaching field.

However, a candidate should adhere to certain conditions to be exempted of NET.  The candidate’s Ph.D degree should be awarded in regular mode and the research thesis should have been evaluated by at least two external examiners. Also, the candidate should have appeared for viva-voce and have published at least two papers based on the Ph.D thesis in research journals.

Ph.D and M.Phil tenure relaxed
The UGC would now allow women and differently-abled students to complete their Ph.D in eight years instead of the present six years and M.Phil in three years instead of two years.

Women candidates will also be provided maternity and child care leave for up to 240 days in the entire duration of their M.Phil or Ph.D degrees, as reported by IndiaTVNews.

In case of relocation of a woman Ph.D or M.Phil scholar due to marriage or otherwise, her research data shall be allowed to be transferred to the university to which the scholar intends to relocate, though subject to certain norms.

The Logical Indian hopes the decisions taken by the UGC and HRD ministry turns out to be good in long run. Now we all have to wait and for the end results of this amendments.
 

Comments

Post a Comment

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em
1 comment
Read more

DoE - Doctrine of Equivalents

The Doctrine of Equivalents is a legal principle that is relevant to patent law, particularly in the United States, and it helps protect inventors' rights even when minor changes or substitutions have been made to a patented invention.  When an inventor applies for a patent, the claims in the patent document define the scope of protection for the invention. These claims outline the specific elements or features of the invention that are considered unique and non-obvious. If another party copies or uses the patented invention without permission, it may be considered infringement. However, in some cases, the accused infringer may make slight modifications to the invention that fall outside the literal scope of the patented claims. The Doctrine of Equivalents comes into play here. It allows the patent holder to assert that the accused infringer's modified version is still equivalent to the patented invention and, therefore, falls within the scope of the patent protection. For the
Post a Comment
Read more

Competitive Landscape for Pharmaceutical Generic products.

Creating a competitive landscape for a pharmaceutical generic product involves analyzing the market and identifying key players, their strengths, weaknesses, and market positioning. Here's a simplified outline: **Competitive Landscape Analysis for Pharmaceutical Generic Product:** 1. **Market Overview:**    - Size of the pharmaceutical generic product market.    - Growth trends and forecasts.    - Regulatory environment and barriers to entry. 2. **Key Players:**    - List the major pharmaceutical companies producing the generic product.    - Include both global and regional players. 3. **Market Share:**    - Percentage of market share held by each major player.    - Trends in market share changes over time. 4. **Product Portfolio:**    - Types of generic products offered by each player.    - Variations in strengths, dosage forms, and delivery methods. 5. ** Competitive Advantage :**    - Identify unique selling points of each player's products.    - Cost advantages, manufacturi
Post a Comment
Read more